[ Inside the business ]

COP stock analysis

COP · Conocophillips

Petroleum refining. Growing 29%.

Watch: growth that has stopped speeding up.

The future, in 7 questions

01 What's priced in?Not available

Needs today's sales, share count and price.

02 Is the wave rising?Industrial cybersecurity · 8.8×
'20'21'22'23'24'2544
#17 of 20 mentioning it
03 Will customers keep buying?Sales +29%, steady
Pipeline 10%Everyone else
Backlog $80M · under 0.1× salesPrepaid $45MSales +29%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Not enough data
Before running costs: 57% → 62%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +2.0%/yrDebt $878M
07 What could break it?2 to watch
  • Growth peaked
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth peaked.

Sales growth −5%, +37%, then +29% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 0.9× the market. In the 2008 crisis it fell 54% while the market fell 51%. Debt is covered by cash.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

68% Lower 48.

Lower 48 68% · Europe, Middle East and North Africa Segment 13% · Alaska Segment 9% · Canada Operating Segment 6% · other (latest quarter)

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

0.7× the economy.

The government expects its industry, petroleum and coal products manufacturing, to grow 1.4% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 201¢ of each $1 of profit.

Competitive advantage

Not measurable.

Returns on capital can't be computed from its filings (common for banks and insurers).

Future bets

$9B committed.

Promised to suppliers, per its latest 10-Q. Plus $78M a year on research (0% of sales).

All figures from Conocophillips's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.